Top Markets
Coin of the day
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rangering i aksjer #33743
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aksjekurs
$4.58
Sist synkronisert: 2025-05-09
Markedsverdi
$6.98M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Kategori

Inntekter for NeuroMetrix, Inc. (NURO)
Inntekter i Dec 2024 TTM: $3.03M
Ifølge de nyeste økonomiske rapportene til NeuroMetrix, Inc. er selskapets nåværende inntekter (TTM) $3.03M. I 2023 hadde selskapet inntekter på $5.90M en nedgang sammenlignet med inntektene i 2022, som var $8.26M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for NeuroMetrix, Inc. fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $3.03M 0.00%
2024 $3.03M -48.61%
2023 $5.90M -28.52%
2022 $8.26M 0.03%
2021 $8.25M 11.87%
2020 $7.38M -20.43%
2019 $9.27M -42.37%
2018 $16.09M -5.86%
2017 $17.09M 42.11%
2016 $12.03M 64.76%
2015 $7.30M 32.42%
2014 $5.51M 4.43%
2013 $5.28M -30.32%
2012 $7.58M -27.14%
2011 $10.40M -25.20%
2010 $13.90M -46.82%
2009 $26.14M -16.01%
2008 $31.12M -30.26%
2007 $44.62M -19.24%
2006 $55.25M 61.09%
2005 $34.30M 91.39%
2004 $17.92M 95.47%
2003 $9.17M 116.98%
2002 $4.23M 21.96%
2001 $3.46M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$46.59B 1,535,920.56%
US
$25.84B 851,808.63%
US
$35.48B 1,169,893.64%
IE
$21.00B 692,189.10%
US
$6.51B 214,626.34%
US